Journal of Inflammation Research (Jul 2022)

Necroptosis-Mediated eCIRP Release in Sepsis

  • Reilly B,
  • Tan C,
  • Murao A,
  • Nofi C,
  • Jha A,
  • Aziz M,
  • Wang P

Journal volume & issue
Vol. Volume 15
pp. 4047 – 4059

Abstract

Read online

Bridgette Reilly,1 Chuyi Tan,1 Atsushi Murao,1 Colleen Nofi,1,2 Alok Jha,1 Monowar Aziz,1– 3 Ping Wang1– 3 1Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, NY, USA; 2Department of Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USA; 3Department of Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY, USACorrespondence: Ping Wang; Monowar Aziz, The Feinstein Institutes for Medical Research, 350 Community Dr., Manhasset, NY, 11030, USA, Tel +1 516 562-3411; +1 516 562-2436, Fax +1 516 562-2396, Email [email protected]; [email protected]: Extracellular cold-inducible RNA-binding protein (eCIRP) is an endogenous pro-inflammatory mediator that exacerbates injury in inflammation and sepsis. The mechanisms in which eCIRP is released have yet to be fully explored. Necroptosis is a programmed cell death that is dependent on the activation of mixed lineage kinase domain-like pseudo kinase (MLKL) which causes the release of damage-associated molecular patterns. We hypothesize that eCIRP is released through necroptosis and intensifies inflammation in sepsis.Methods: RAW264.7 cells were treated with pan-caspase inhibitor z-VAD (15 μM) 1 h before stimulation with LPS (1 μg/mL). Necroptosis inhibitor, Necrostatin-1 (Nec-1) (10 μM) was added to the cells with LPS simultaneously. After 24 h of LPS stimulation, cytotoxicity was determined by LDH assay. eCIRP levels in the culture supernatants and phospho-MLKL (p-MLKL) from cell lysates were assessed by Western blot. p-MLKL interaction with the cell membrane was visualized by immunofluorescence. Sepsis was induced in C57BL/6 mice by cecal ligation and puncture (CLP). Mice were treated with Nec-1 (1 mg/kg) or DMSO. 20 h post-surgery, serum and peritoneal fluid levels of eCIRP, TNF-α and IL-6 were determined by ELISA. H&E staining of lung tissue sections was performed.Results: We found that in RAW264.7 cells, LPS+z-VAD induces necroptosis as evidenced by an increase in p-MLKL levels and causes eCIRP release. Nec-1 reduces both p-MLKL activation and eCIRP release in LPS+z-VAD-treated RAW264.7 cells. Nec-1 also inhibits the release of eCIRP, TNF-α and IL-6 in the serum and peritoneal fluid in CLP-induced septic mice. We predicted a transient interaction between eCIRP and MLKL using a computational model, suggesting that eCIRP may exit the cell via the pores formed by p-MLKL.Conclusion: Necroptosis is a novel mechanism of eCIRP release in sepsis. Targeting necroptosis may ameliorate inflammation and injury in sepsis by inhibiting eCIRP release.Keywords: eCIRP, necroptosis, Necrostatin-1, macrophage, sepsis

Keywords